Victoza (Liraglutide) Solution For Injection, 6MG/ML



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 65.6%
Product Used For Unknown Indication 29.4%
Diabetes Mellitus 3.7%
Glucose Tolerance Impaired 0.5%
Type 1 Diabetes Mellitus 0.3%
Weight Decreased 0.2%
Blood Glucose Increased 0.1%
Metabolic Syndrome 0.1%
Polycystic Ovaries 0.1%
Rheumatoid Arthritis 0.1%
Weight Increased 0.1%
Nausea 23.0%
Pancreatitis 14.6%
Vomiting 11.9%
Blood Glucose Increased 8.7%
Weight Decreased 5.5%
Injection Site Pain 5.0%
Decreased Appetite 3.7%
Diarrhoea 3.6%
Injection Site Haematoma 3.3%
Injection Site Urticaria 2.3%
Blood Glucose Decreased 2.2%
Headache 2.2%
Drug Ineffective 2.1%
Malaise 2.1%
Pancreatitis Acute 2.0%
Constipation 1.7%
Weight Increased 1.6%
Injection Site Mass 1.5%
Urticaria 1.5%
Fatigue 1.4%
Secondary
Type 2 Diabetes Mellitus 56.1%
Product Used For Unknown Indication 31.7%
Diabetes Mellitus 12.2%
Blood Glucose Increased 25.0%
Malaise 10.0%
Blood Pressure Increased 5.0%
Decreased Appetite 5.0%
Diabetes Mellitus Inadequate Control 5.0%
Flatulence 5.0%
Injection Site Pain 5.0%
Injection Site Rash 5.0%
Injection Site Urticaria 5.0%
Myalgia 5.0%
Nausea 5.0%
Needle Issue 5.0%
Vomiting 5.0%
Weight Increased 5.0%
Wrong Drug Administered 5.0%
Concomitant
Type 2 Diabetes Mellitus 100.0%
Weight Fluctuation 100.0%